Carvedilol ER 10 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL8K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,616
Award facts
- Contract value 100% obligated
- $10,616.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,616.33 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad range of products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. The company competes on a full and open basis for federal contracts, with its delivery orders typically structured as firm fixed-price transactions. This particular order for Carvedilol, a cardiovascular medication, exemplifies the routine pharmaceutical supply operations that AmerisourceBergen executes through its substantial relationship with the Defense Logistics Agency Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FFL8K?
SPE2DR26FFL8K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FFL8K worth?
The government has obligated $10,616 on SPE2DR26FFL8K.
Is contract SPE2DR26FFL8K an order under another contract?
Yes. SPE2DR26FFL8K is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL8K competed?
The extent of competition for SPE2DR26FFL8K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award